|
Oct 2
|
Legal Battle Brews Over 23andMe's Customer Data Breach Settlement And Arbitration Claimants
|
|
Oct 1
|
23andMe no longer open to third-party takeover bids - filing
|
|
Sep 30
|
23andMe CEO Wojcicki no longer open to third-party takeover proposals, filing shows
|
|
Jul 25
|
23andMe to Report Q1 FY2025 Financial Results
|
|
Jul 25
|
Twenty Lung Cancer Advocacy Organizations and 23andMe Come Together to Launch Lung Cancer Genetics Study to Help Advance Research
|
|
Jul 24
|
The 3 Best Personalized Nutrition Stocks to Buy Now
|
|
May 29
|
Largest study on the LRRK2 variant leads to discoveries about health, ancestry, and history
|
|
May 25
|
23andMe Holding Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
|
|
May 24
|
Q4 2024 23andMe Holding Co. Earnings Call
|
|
May 14
|
Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros Pharmaceuticals
|
|
May 10
|
Struggling 23andMe Granted Extension to Revive Stock Price
|
|
May 9
|
23andMe to Report Q4 and Full Year FY2024 Financial Results
|
|
Apr 26
|
7 Best Sites Like Ancestry.com to Research Your Family History
|
|
Apr 24
|
23andMe to Present Preliminary Efficacy and Biomarker Data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
|
|
Apr 23
|
This Technology Company Is Being Acquired at a Shocking 207% Premium -- and These 2 Stocks Could Be Next
|
|
Apr 19
|
23andMe CEO Anne Wojcicki Says She’s Weighing Buyout Bid
|
|
Apr 18
|
Stocks to Watch Thursday: TSMC, Netflix, Nvidia, Tesla
|
|
Apr 18
|
23andMe Stock Jumps on News of Plans to Take It Private
|
|
Apr 18
|
23andMe CEO Anne Wojcicki Plans to Take Company Private
|
|
Apr 18
|
23andMe Jumps as CEO Floats Taking DNA Tester Private
|